CB vs PMCB · P/E 14, rev $59.40B vs $8.6M cap
Chubb Ltd (CB) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the CB and PMCB stock pages for the full models.
Not investment advice.